Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Choosing the right accounts—taxable, tax-advantaged, or retirement—can significantly reduce taxes on index fund gains and distributions.
25,988 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Ripple and North Island Ventures have led a $6 million funding round for Squid, the cross-chain platform, as the comp...
As AI data centers push energy use higher, nuclear power is being framed as the only real baseload option. This piece...
Institutional traders are piling into XRP spot buying while the futures market cools, signaling a pivot in market par...
An agreement settles customer claims against ftx’s former firm, auditor for $66 million, without admission of wrongdo...
Oil markets roiled by Hormuz disruptions push energy ETFs past the 50% mark for the year, prompting a closer look at ...
Blackstone's flagship private-credit fund drew heavier redemptions than typical, underscoring strain in private credi...
A potential agreement with Iran could unlock sanctions relief, release frozen assets, and reopen Gulf shipping. Negot...
Rivian priced a 75 million share secondary offering, sending its stock down around 14% and triggering a market-wide p...
A large fund trimmed its DigitalBridge position, sparking questions about stake moves, stock momentum, and how invest...
The levered BOIL ETF aims for double daily moves in natural gas, but ongoing contango and roll costs erode value for ...
BonkDAO’s governance proposal drained roughly $20 million in BONK from its treasury, underscoring a new risk surface ...